To test this hypothesis, we enhanced the P2RX7/IL-18 axis in the BLM-induced lung fibrosis mouse model by using HEI3090, a chemical compound described to stimulate immune cells expressing P2RX7 to generate IL-18 in the presence of eATP (Douguet et al., 2021). The gene discussed is IL18; the disease is Bloom syndrome.